Consent concerns in clinical trials of investigational therapies for COVID-19: Vulnerability versus voluntariness

Obtaining informed consent from vulnerable patients participating in clinical trials of investigational therapies for COVID-19 is a major ethical challenge. Ethical and operational considerations – voluntariness, waiver, timing, time, documentation, and responsibilities of the sponsor, the investiga...

Descripción completa

Detalles Bibliográficos
Autor principal: Bhatt, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Ethics Education
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819368/
https://www.ncbi.nlm.nih.gov/pubmed/33489836
http://dx.doi.org/10.4103/picr.PICR_271_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819368/
https://www.ncbi.nlm.nih.gov/pubmed/33489836
http://dx.doi.org/10.4103/picr.PICR_271_20

Ejemplares similares